Amendment ID: S2133-13-R1

Redraft Amendment 13

DPH Licensure Requirements for Substance Use Treatment Providers

Mr. Tarr, Ms. Lovely and Ms. Candaras move to amend the bill by inserting at the end thereof the following new section:-

SECTION X. Section 19 of Chapter 17 of the General Laws is hereby amended by striking the section in its entirety and inserting in its place the following new section:

Section 19. Regulations relative to coordination of care and discharge planning for substance use treatment programs subject to licensure or approval

Section 19. The department shall promulgate regulations relative to coordination of care and management that includes effective discharge planning for substance abuse treatment programs subject to licensure or approval under sections 24 and 24D of chapter 90, sections 6 and 6A of chapter 111B and section 7 of chapter 111E. The regulations shall include, but not be limited to the following requirements:

1)provide enhanced care coordination and management that includes effective discharge planning, that engages and educates the patient and the patient’s outpatient medical and psychiatric providers to ensure continuity of care;

2)provide a discharge plan to each client leaving a licensed substance abuse treatment program that shall include recommended follow-up treatment, contact information for shelters in the area, additional resources for substance abuse treatment and workforce options, and providing and linking to community and social supports; and information on family support services

3)provide patient-centric treatment that is individualized based on the patient’s past history of treatment, medical history, psychiatric history, and socialize history;

4)facilitate transitions from more intensive to less intensive treatment based on the patient’s needs and response to treatment;

5)upon admission, acquire informed consent from each patient regarding the risk and benefit of all MAT treatment options, as well as the risk and benefit of non-treatment; and

6)provide regular monitoring of patients’ behavior and addressing relapse risks;